美国Cytori Therapeutics
GE Healthcare将在北美干细胞银行与储存市场商业行销Cytori的StemSource技术，StemSource技术包括自动化设备，可处理脂肪组织里面的干细胞与再生细胞。

Cytori Therapeutics is a global leader in regenerative medicine.

In the US, Cytori has developed technology to assist the physician in reconstructive and aesthetic surgery procedures. Our key technology is the Celution® 700 system that prepares an autologous tissue graft for delivery back to the patient in the same surgical procedure. This innovative technology is under review by the US Food and Drug Administration but is not available today in the US.

Internationally, Cytori’s technology is commercially available today in many countries in Europe and Asia through our offices in Japan, Italy or our global distribution partners. In addition, Cytori is currently investigating the use of our technology for many indications beyond reconstructive and aesthetic surgery. Please link to the international website for information on Cytori’s technology that is available to help patients around the world.